A Blueprint for Broadly Effective Phage-Antibiotic Cocktails
SciFocus/Dec 3, 2024/USA -- Stanford University researchers unveil a groundbreaking strategy to combat multidrug-resistant (MDR) bacterial infections using bacteriophage-antibiotic combinations. By systematically identifying complementary phages and pairing them with specific antibiotics, this innovative approach delivers broad-spectrum efficacy against deadly pathogens.
"Study provides a blueprint for developing off-the-shelf bacteriophage-antibiotic cocktails that target multidrug-resistant infections effectively, paving the way for scalable solutions to a critical global health challenge."
Key Highlights:
This innovative framework promises to revolutionize phage therapy, overcoming challenges like narrow host range and resistance, to tackle the escalating threat of antibiotic-resistant infections.
If you're enjoying this content, sign up to SciFocus daily newsletter by Biopatrika for all the biggest stories in Science, healthcare, STEM, startups, and how we're advocating to "Bring Science to Society." #SciFocus #BioPatrika
For partnership or advertisement opportunities, feel free to contact us here or at [email protected].
Career Opportunities: Biopatrika Career Hub https://www.dhirubhai.net/groups/13946324/
Follow Virender Singh and Biopatrika on LinkedIn.